6/13/2022How American Companies are Approaching China's Data, Privacy, and Cybe...

6/13/2022Organon Enters Licensing Deal with Chinese Biotech Henlius for Biosimi...

6/13/2022Gavi: Chinese Vaccine to Play Major Role in Future Health Challenges

6/10/2022NHC and SATCM Issue the Rules for Internet Diagnosis and Treatment Reg...

6/10/2022Drug R&D and Product Registration News Digest June 2022 (1)

6/10/2022Delisting Risk, Souring Relations Are Hurdles for Chinese Biotech Firm...

6/9/2022OnCusp and Multitude Enter into an Ex-China Licensing Agreement for a ...

6/8/2022Nicholas Hall Reports Improved Chinese OTC GI Market Growth for 2021 B...

6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...

6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021

6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031

6/7/2022CanSino and Pfizer Terminate vaccine deal

6/7/2022Fosun Pharma Acquires 60% of Singapore OncoCare Medical for $158M

6/7/2022China Issues the Notice on Correction of Irregularities in Drug Procur...

6/7/2022How Shanghai Kept Clinical Trials Going During Lockdown (PharmaDJ)

6/6/2022CDE Issues the Statistical Guidelines for Clinical Research of Rare Di...

6/6/2022Pfizer/CStone Cejemly Gets China Approval for Expanded Use in Advanced...

6/6/2022Kexing Soars After Signing Salubris to Develop, Make Oral Covid-19 Dru...

6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...

6/6/2022China Issues the 14th Five-Year National Health Plan with A New Focus ...

6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification

6/3/2022NMPA Speeds Up Approval of Pediatric Drugs

6/3/2022Patient Activeness During Online Medical Consultation in China: Multil...

6/2/2022NMPA Solicits Comments on the Draft Good Manufacturing Practices for D...

6/2/2022Delayed NEDL Revision Process To Be Restarted Soon

6/2/2022China to Initiate Nationwide Unannounced BMI Fund Inspection

6/2/2022Zelixir Biotech Looks to Help Global Monkeypox Drug Development

6/1/2022Xuanzhu and CTTQ-Akeso Tie Up to Develop Penpulimab for Solid Tumors

6/1/2022Pharma Cos Accelerate Repositioning amid Rising Uncertainties and Macr...

5/31/2022Rough Discussion On Experimental Data Submitted After Application Fili...

Page:164/801 Total number of articles:24019: [First][<<] [162] [163] [164] [165] [166] [>>] [End]